What is the recommended management of a urinary tract infection?

Management of Urinary Tract Infections

Initial Classification and Diagnosis

The first critical step is to classify the UTI as either uncomplicated or complicated, because this fundamentally determines treatment duration, antibiotic selection, and need for urine culture. 1, 2

Uncomplicated UTI Criteria

• Occurs in non-pregnant, non-elderly women without recent instrumentation, antimicrobial treatment, or known functional/anatomic genitourinary abnormalities 3
• In women with typical symptoms (frequency, urgency, dysuria, nocturia, suprapubic pain) without vaginal discharge, self-diagnosis is >90-95% accurate and treatment can begin without laboratory testing 4, 5
• Urine culture is not required for uncomplicated cystitis in women with classic symptoms 4

Complicated UTI Criteria

• All UTIs in men are automatically classified as complicated and require 7-14 days of treatment (14 days preferred when prostatitis cannot be excluded) 1, 2
• Presence of structural/functional urinary tract abnormalities, immunosuppression, pregnancy, diabetes, indwelling catheters, recent instrumentation, or healthcare-associated acquisition 2, 6
• Detection of ESBL-producing or multidrug-resistant organisms automatically classifies the infection as complicated 7
• Obtain urine culture with susceptibility testing before starting antibiotics in all complicated UTIs, men, recurrent infections, treatment failures, or atypical presentations 1, 2, 4

---

First-Line Treatment for Uncomplicated Cystitis in Women

Nitrofurantoin 100 mg twice daily for 5 days is the preferred first-line agent because resistance rates remain low (<5%), it has minimal collateral damage to normal flora, and does not share cross-resistance with other commonly prescribed antimicrobials 1, 4, 8

Alternative First-Line Options

• Fosfomycin 3 g single dose – convenient single-dose therapy with low resistance 9, 4, 8
• Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 3 days – only when local E. coli resistance is <20% 4, 5, 8
• Trimethoprim 100 mg twice daily for 3 days – when TMP-SMX resistance is low 4

Second-Line Agents (Use Only When First-Line Unavailable)

• Fluoroquinolones (ciprofloxacin, levofloxacin) should be reserved for complicated infections or when first-line agents cannot be used due to allergy or resistance 3, 8
• Beta-lactams (amoxicillin-clavulanate, cephalosporins) have 15-30% higher failure rates compared to first-line agents and should be given for 7 days if used 1, 5

Critical Pitfall

• Never use nitrofurantoin or fosfomycin for complicated UTIs, pyelonephritis, or when upper tract involvement is suspected – these agents achieve insufficient tissue concentrations outside the bladder 2, 7, 10

---

Treatment for Complicated UTIs and Pyelonephritis

Empiric Parenteral Therapy (Severe Illness, Hospitalization Required)

• Ceftriaxone 1-2 g IV/IM once daily (use 2 g for complicated infections) provides broad-spectrum coverage while awaiting culture results 2, 7
• Alternative parenteral options: cefepime 1-2 g IV every 12 hours, piperacillin-tazobactam 3.375-4.5 g IV every 6 hours, or aminoglycosides (gentamicin 5 mg/kg once daily) 7, 10
• Carbapenems should be reserved for ESBL-producing organisms or multidrug-resistant pathogens 7, 10

Oral Therapy for Mild-Moderate Complicated UTI

• Ciprofloxacin 500-750 mg twice daily for 7 days – preferred when local fluoroquinolone resistance is <10% and organism is susceptible 1, 2, 6
• Levofloxacin 750 mg once daily for 5-7 days – equivalent efficacy to ciprofloxacin 2, 6
• Trimethoprim-sulfamethoxazole 160/800 mg twice daily for 14 days – when organism is susceptible and fluoroquinolones contraindicated 2, 6

Oral Step-Down After Initial IV Therapy

• Transition to oral therapy once afebrile ≥48 hours and hemodynamically stable 2, 7
• Use the same oral agents listed above based on culture susceptibility results 2, 6
• Oral cephalosporins have higher failure rates and should only be used when preferred agents are unavailable 1, 2

---

Treatment Duration Guidelines

Uncomplicated Cystitis in Women

• Nitrofurantoin: 5 days 4
• Fosfomycin: single dose 9, 4
• TMP-SMX or trimethoprim: 3 days 4, 5
• Beta-lactams (if used): 7 days 5

Complicated UTIs

• 7 days total when symptoms resolve promptly, patient remains afebrile ≥48 hours, and no upper tract involvement 2, 7
• 14 days total for delayed clinical response (fever >72 hours), male patients when prostatitis cannot be excluded, or presence of urological abnormalities 1, 2, 7

Special Populations

• All UTIs in men require 7-14 days (14 days preferred) 1, 2
• Catheter-associated UTIs: 7 days if prompt resolution, 10-14 days if delayed response 7

---

Prevention of Recurrent UTIs (>2 in 6 months or >3 in 1 year)

Postmenopausal Women

• Vaginal estrogen with or without lactobacillus-containing probiotics is first-line prevention 1, 2, 6
• Vaginal estrogen may cause vaginal irritation but reduces recurrence rates 2

Premenopausal Women with Post-Coital Infections

• Low-dose antibiotic within 2 hours of sexual activity for 6-12 months (nitrofurantoin 50 mg, TMP-SMX 40/200 mg, or trimethoprim 100 mg) 1, 2

Premenopausal Women with Non-Coital Infections

• Daily antibiotic prophylaxis (nitrofurantoin preferred) reduces UTI rate to 0.4/year – most effective strategy 2, 6
• Rotate antibiotics at 3-month intervals to avoid resistance 1

Non-Antibiotic Alternatives

• Methenamine hippurate and/or lactobacillus-containing probiotics 1, 2
• Cranberry products 100-500 mg daily may provide modest benefit 2
• Oral immunostimulant (OM-89) shows promise 2

---

Critical Management Principles to Avoid Common Pitfalls

What NOT to Do

• Never treat asymptomatic bacteriuria in women with recurrent UTIs or catheterized patients – this fosters resistance and increases recurrence 1, 2, 6, 7
• Never classify recurrent UTI patients as "complicated" unless they have structural abnormalities, immunosuppression, or pregnancy – this leads to unnecessary broad-spectrum antibiotics 1
• Never use fluoroquinolones empirically when local resistance exceeds 10% or patient has recent fluoroquinolone exposure 1, 2, 7
• Never use broad-spectrum antibiotics for extended durations when narrower agents are appropriate 1, 6

What TO Do

• Obtain pretreatment urine culture when acute UTI is suspected in patients with recurrent infections, and use prior culture data to guide empiric therapy while awaiting results 1
• Consider self-start antibiotic therapy for reliable patients who can obtain urine specimens before starting therapy and communicate effectively 1, 2
• If persistent symptoms despite treatment, repeat urine culture before prescribing additional antibiotics 1
• Use nitrofurantoin when possible for re-treatment since resistance is low and decays quickly if present 1
• Address underlying urological abnormalities (obstruction, incomplete voiding, foreign bodies) because antimicrobial therapy alone is insufficient without source control 2, 7

---

Antibiotic Selection Based on Local Resistance Patterns

• When local TMP-SMX resistance exceeds 20%, use alternative first-line agents 4, 5
• When local fluoroquinolone resistance exceeds 10%, avoid empiric fluoroquinolone use 1, 2
• Consider patient's prior organism identification and susceptibility profile when selecting prophylactic antibiotics 1
• Nitrofurantoin maintains low resistance rates and should be prioritized when appropriate 1, 8